Skip to main content
. 2016 Apr 22;60(5):3174–3177. doi: 10.1128/AAC.03029-15

FIG 2.

FIG 2

Chart comparing vancomycin and oritavancin MIC results for 5,609 S. aureus surveillance program isolates obtained in the United States and Europe in 2014. Organisms with reproducible oritavancin-nonsusceptible results (MICs of 0.25 μg/ml) are shown (only 3 isolates [0.05%]).